Exscientia has advanced a drug candidate for Alzheimer's disease into human testing ... compulsive disorder billed as the first AI-designed drug to enter the clinic. Exscientia says it is the ...

New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced ...

Both FDA-approved medications are designed to remove amyloid beta plaques from the brains of people with early-stage Alzheimer's disease, potentially slowing the rate of cognitive decline.

The 94-year-old died of heart disease and complications caused by Alzheimer’s disease, according to the New Mexico Office of the Medical Investigator. Alzheimer’s disease is a brain disorder ...

A puzzling discovery has left doctors scratching their heads: The brain of an American woman with Down syndrome showed all the classic signs of Alzheimer’s disease, yet she remained symptom-free ...

Commissions do not affect our editors' opinions or evaluations. Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according to ...

A bill calls for the implementation of an Alzheimer’s Disease Awareness Program that would better educate residents on the ...

Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease. Unlike the acute, short-lived inflammation that combats infection ...

Additionally, our AI models are designed to predict potential biomarkers for the early detection of Alzheimer's, optimize clinical trials, and predict receptor affinity, among others. With 32 ...